Interview: Ernest Bartosik, Country Manager, Unipharm, Poland
Unipharm Poland’s country manager explains what is needed to become a successful OTC and dietary supplement company in Poland, saying that it is “key to master the marketing mix but…
Unipharm is an American pharmaceutical company specializing in the development and marketing of quality over-the-counter (OTC) drugs and nutritional products. Since it was established in the USA in 1992, the Company has consistently grown, and continues to provide award-winning, quality products to its loyal customers in many different countries.
Unipharm has been for many years registered with the US Food and Drug Administration. All of Unipharm’s products are made in the USA under extensive quality control supervision at well-established facilities that follow Good Manufacturing Practice (GMP) guidelines and United States Pharmacopeia (USP) standards. We are also proud to be certified by National Sanitation Foundation (NSF) International. In addition, our products are manufactured, tested and packaged according to regulations mandated by every country the Company sells in.
The world headquarters of Unipharm is located here in the Empire State Building in New York City, and there are many branch offices worldwide. Unipharm products are successful, both in terms of brand awareness and sales, and this is demonstrated by the kind of loyalty that you, our loyal customers, demonstrate to us. The Company is committed to continue offering a wide variety of quality goods that are both safe and effective.
In Poland Unipharm’s offer is dedicated to physicians, their patients, and consumers in area of joint care, bone health, osteoporosis, beauty, aging, memory loss and immune support. The Company is deeply engaged in both health education and activities which support healthy life, medical prophylaxis and treatment.
Unipharm Poland’s country manager explains what is needed to become a successful OTC and dietary supplement company in Poland, saying that it is “key to master the marketing mix but…
Stefan Buguslawski, president of PEX Pharmasequence, a leading Polish healthcare consultancy and market research company, highlights the current obstacles facing the Polish healthcare market and the dynamics of the domestic…
Piotr Ponikowski, president of the Polish Cardiac Society, discusses the positive steps Poland is taking to construct an effective program against cardiovascular disease as well as the importance of a…
Wojciech Sulimierski, general manager of Aspen Poland and CEE, discusses the opening of the regional operations in 2014 and the importance of the CEE region as the company establishes itself…
Jarek Oleszczuk, country president of AstraZeneca Poland, the leading R&D investor in Poland, discusses the exciting milestones that the company has achieved, including reimbursement of two breakthrough oncology therapies, as…
Drago Vuina, corporate vice-president of Novo Nordisk Eastern Europe, highlights Poland as the most significant market in the region and the on-going commitment to make innovative treatment options available for…
Jakub Szulc, director of life sciences at EY Poland, discusses the exciting opportunities that exist within the healthcare sector in the flourishing Polish economy and the overriding need to increase…
Samantha Kingdom, general manager of Amgen Poland, highlights her strategy to be a significant contributor within the Polish healthcare space, while delivering highly innovative products to significantly improve Polish patients’…
Jacek Mazurkiewicz, general manager of AbbVie Poland, discusses the recent exciting achievements of the affiliate, including the reimbursement of its products in recent years and the set up one of…
Maciej Kuźmierkiewicz, general manager of IQVIA Poland and the Baltics, discusses the implications of global changes on the Polish affiliate (which now employs 1000 staff) and the challenges of promoting…
Wojciech Koziejowski, managing director of Lundbeck Poland, discusses attaining reimbursement in Poland for the first time in ten years and the recent set-up of their global shared service center of…
Denis Vujičić, managing director of MSD Poland, discusses his overriding mission to give Polish patients greater access to breakthrough therapies and highlights the affiliate’s extensive R&D capabilities that entail both…
Irena Rej, president of the Polish Pharmaceutical Chamber, Farmacja Polska, discusses the trends of the domestic pharmaceutical market and the recent changes to improve the introduction of innovative products. Furthermore,…
See our Cookie Privacy Policy Here